On this episode I was joined by Bob Nesbitt, Chair of ISO TC 84 and Director of Combination Products R&D at Abbvie. Bob discusses:
Key Topics
- ISO TC 84: Needle Based Injectors, Insulin Syringes, Auto Disable Syringes, On Body Injectors, Sharps Prevention, Cartridge Based Pen Injectors, Inhalers, Single use Drug Delivery devices, Catheters, etc
- Crazy Bob's Medical Device
- Relationship between AAMI, ANSI, and ISO
- Committee work for industry and advancing the State of the Art
- Bob's Book Recommendation: The Immortal Life of Henrietta Lacks (Link)
Bob Nesbitt, is Senior Director, E2E Combination Product, Platform, and Process Development at Abbvie. After “retiring” from Eli Lilly In January 2015, Bob joined Abbvie's Combination Product Development group, where he led the Human Factors group. At Lilly, Bob lead a team that created over a dozen drug delivery devices; taking them from concept to reality. Bob has been involved in the US and International Standards (ISO) Community sInce 1999, working with passionate, knowledgeable Medical Device and Standards personnel from all over the world to create standards which "raise the bar" in Patient Safety in this regulated industry. Currently, he serves as the ISO International Chair for TC84. Prior to becoming chair of TC 84, Bob was an Expert or Convener for various committees, and was the Industry Co-Chair for US TC84 TAG from 2004-2020.
